To all our CKB CORE users, don’t miss the latest new features now available! Register for a free CORE account here and then login for access. Feel free to contact us at ckbsupport@genomenon.com if you have any questions!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04475939
Title Placebo-controlled Study Comparing Niraparib Plus Pembrolizumab Versus Placebo and Pembrolizumab as Maintenance Therapy (ZEAL-1L)
Acronym ZEAL-1L
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors GlaxoSmithKline
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | TUR | SWE | ROU | POL | NOR | NLD | ITA | IRL | HUN | GRC | GBR | FRA | ESP | DEU | CHE | BRA | BGR | BEL | AUS | ARG

Facility Status City State Zip Country Details
GSK Investigational Site Fullerton California 92835 United States Details
GSK Investigational Site Los Angeles California 90017 United States Details
GSK Investigational Site Lone Tree Colorado 80128 United States Details
GSK Investigational Site Norwich Connecticut 06360 United States Details
GSK Investigational Site Tallahassee Florida 32003 United States Details
GSK Investigational Site Atlanta Georgia 30322 United States Details
GSK Investigational Site Newnan Georgia 30265 United States Details
GSK Investigational Site Niles Illinois 60714 United States Details
GSK Investigational Site Iowa City Iowa 52242 United States Details
GSK Investigational Site Worcester Massachusetts 01655 United States Details
GSK Investigational Site Mineola New York 10016 United States Details
GSK Investigational Site New York New York 10016-4744 United States Details
GSK Investigational Site Charlotte North Carolina 28207 United States Details
GSK Investigational Site Pittsburgh Pennsylvania 15212 United States Details
GSK Investigational Site Chattanooga Tennessee 37404 United States Details
GSK Investigational Site Nashville Tennessee 37203 United States Details
GSK Investigational Site Dallas Texas 75246 United States Details
GSK Investigational Site San Antonio Texas 78217 United States Details
GSK Investigational Site Sugar Land Texas 77479 United States Details
GSK Investigational Site Waco Texas 76712 United States Details
GSK Investigational Site Fairfax Virginia 08613 United States Details
GSK Investigational Site Buenos Aires C1125ABD Argentina Details
GSK Investigational Site Buenos Aires C1426ABP Argentina Details
GSK Investigational Site Cipoletti Rio Negro R8324CVE Argentina Details
GSK Investigational Site Ciudad Autonoma de Buenos Aire C1426AGE Argentina Details
GSK Investigational Site Cordoba X5004FHP Argentina Details
GSK Investigational Site Florida 1602 Argentina Details
GSK Investigational Site La Plata 1900 Argentina Details
GSK Investigational Site Rosario S2000DSV Argentina Details
GSK Investigational Site Blacktown New South Wales 2148 Australia Details
GSK Investigational Site Hobart Tasmania 7000 Australia Details
GSK Investigational Site Ballarat Victoria 3350 Australia Details
GSK Investigational Site Heidelberg Victoria 3084 Australia Details
GSK Investigational Site Bruxelles 1200 Belgium Details
GSK Investigational Site Edegem 2650 Belgium Details
GSK Investigational Site Leuven 3000 Belgium Details
GSK Investigational Site Roeselare 8800 Belgium Details
GSK Investigational Site Belo Horizonte 30110-022 Brazil Details
GSK Investigational Site Cachoeiro Do Itapemirim 29308-014 Brazil Details
GSK Investigational Site Curitiba 80040-170 Brazil Details
GSK Investigational Site Porto Alegre 90610-000 Brazil Details
GSK Investigational Site Rio de Janeiro 22250-905 Brazil Details
GSK Investigational Site SAo Paulo 01308-901 Brazil Details
GSK Investigational Site Sao Paulo 01509-010 Brazil Details
GSK Investigational Site UberlAndia 38408-150 Brazil Details
GSK Investigational Site Panagyurishte 4500 Bulgaria Details
GSK Investigational Site Pleven 5800 Bulgaria Details
GSK Investigational Site Plovdiv 4004 Bulgaria Details
GSK Investigational Site Ruse 7002 Bulgaria Details
GSK Investigational Site Sofia 1632 Bulgaria Details
GSK Investigational Site Santiago 7500653 Chile Details
GSK Investigational Site Santiago 7500921 Chile Details
GSK Investigational Site Temuco 5360000 Chile Details
GSK Investigational Site Bogota 5600520 Colombia Details
GSK Investigational Site Monteria 230018 Colombia Details
GSK Investigational Site Brest cedex 29609 France Details
GSK Investigational Site CrEteil cedex 94010 France Details
GSK Investigational Site Grenoble Cedex 9 38043 France Details
GSK Investigational Site Lille 59037 France Details
GSK Investigational Site Paris 75014 France Details
GSK Investigational Site Paris 75018 France Details
GSK Investigational Site Rennes 35033 France Details
GSK Investigational Site Saint-Herblain 44093 France Details
GSK Investigational Site Strasbourg 67200 France Details
GSK Investigational Site Toulon cedex 83056 France Details
GSK Investigational Site Toulouse cedex 9 31059 France Details
GSK Investigational Site Berlin 13125 Germany Details
GSK Investigational Site Bonn 53113 Germany Details
GSK Investigational Site Essen 45147 Germany Details
GSK Investigational Site Frankfurt 60488 Germany Details
GSK Investigational Site Gauting 82131 Germany Details
GSK Investigational Site Grosshansdorf 22927 Germany Details
GSK Investigational Site Halle 06120 Germany Details
GSK Investigational Site Hamburg 20251 Germany Details
GSK Investigational Site Hannover 30459 Germany Details
GSK Investigational Site Heidelberg 69126 Germany Details
GSK Investigational Site Hemer 58675 Germany Details
GSK Investigational Site Jena 07747 Germany Details
GSK Investigational Site Muenchen 81925 Germany Details
GSK Investigational Site MUnchen 80336 Germany Details
GSK Investigational Site Stuttgart 70376 Germany Details
GSK Investigational Site Velbert 42551 Germany Details
GSK Investigational Site Athens 115 27 Greece Details
GSK Investigational Site Athens 11526 Greece Details
GSK Investigational Site Athens 11528 Greece Details
GSK Investigational Site Athens 12462 Greece Details
GSK Investigational Site Athens 15125 Greece Details
GSK Investigational Site Athens 15562 Greece Details
GSK Investigational Site Athens 185 37 Greece Details
GSK Investigational Site Heraklion Crete 71110 Greece Details
GSK Investigational Site Larissa 41110 Greece Details
GSK Investigational Site Neo Faliro 185 47 Greece Details
GSK Investigational Site Patras 26500 Greece Details
GSK Investigational Site Pylaia Thessaloniki 57001 Greece Details
GSK Investigational Site Rio Patras 26500 Greece Details
GSK Investigational Site Thessaloniki 54007 Greece Details
GSK Investigational Site Thessaloniki 54622 Greece Details
GSK Investigational Site Thessaloniki 54645 Greece Details
GSK Investigational Site Thessaloniki 57010 Greece Details
GSK Investigational Site Budapest 1083 Hungary Details
GSK Investigational Site Budapest H-1122 Hungary Details
GSK Investigational Site GyOngyOs 3200 Hungary Details
GSK Investigational Site TatabAnya 2800 Hungary Details
GSK Investigational Site TOrOkbAlint 2045 Hungary Details
GSK Investigational Site Cork T12 DFK4 Ireland Details
GSK Investigational Site Dublin 8 Ireland Details
GSK Investigational Site Avellino 83100 Italy Details
GSK Investigational Site Aviano PN 33081 Italy Details
GSK Investigational Site Bari 70124 Italy Details
GSK Investigational Site Catania 95123 Italy Details
GSK Investigational Site Firenze 50134 Italy Details
GSK Investigational Site Milano 20122 Italy Details
GSK Investigational Site Milano 20132 Italy Details
GSK Investigational Site Milano 20133 Italy Details
GSK Investigational Site Monza 20900 Italy Details
GSK Investigational Site Napoli 80131 Italy Details
GSK Investigational Site Orbassano TO 10043 Italy Details
GSK Investigational Site Pisa 56124 Italy Details
GSK Investigational Site Roma 00168 Italy Details
GSK Investigational Site Verona 37045 Italy Details
GSK Investigational Site Seongnam-si Gyeonggi-do 13620 Korea, Republic of Details
GSK Investigational Site Seongnam-si 463-712 Korea, Republic of Details
GSK Investigational Site Seoul 05505 Korea, Republic of Details
GSK Investigational Site Seoul 08308 Korea, Republic of Details
GSK Investigational Site Suwon Kyunggi-do 443-721 Korea, Republic of Details
GSK Investigational Site Mexico City 03100 Mexico Details
GSK Investigational Site Mexico City 06700 Mexico Details
GSK Investigational Site Mexico City CP 14080 Mexico Details
GSK Investigational Site Monterrey 64460 Mexico Details
GSK Investigational Site Puebla Puebla 72560 Mexico Details
GSK Investigational Site Amersfoort 3813 TZ Netherlands Details
GSK Investigational Site Amsterdam 1066 CX Netherlands Details
GSK Investigational Site Den Bosch 5223 GZ Netherlands Details
GSK Investigational Site Enschede 7512 KZ Netherlands Details
GSK Investigational Site Maastricht 6229 HX Netherlands Details
GSK Investigational Site Utrecht 3543 AZ Netherlands Details
GSK Investigational Site Zwolle 8025 AB Netherlands Details
GSK Investigational Site Drammen N-3004 Norway Details
GSK Investigational Site Lrenskog 1470 Norway Details
GSK Investigational Site Oslo N-0450 Norway Details
GSK Investigational Site Lima Lima 34 Peru Details
GSK Investigational Site Bialystok 15-540 Poland Details
GSK Investigational Site Lodz 90-338 Poland Details
GSK Investigational Site Olsztyn 10-357 Poland Details
GSK Investigational Site Bucuresti 011654 Romania Details
GSK Investigational Site Bucuresti 022328 Romania Details
GSK Investigational Site Cluj-Napoca 400015 Romania Details
GSK Investigational Site Craiova 200542 Romania Details
GSK Investigational Site Iasi 700483 Romania Details
GSK Investigational Site Satu Mare 440055 Romania Details
GSK Investigational Site Timisoara 300239 Romania Details
GSK Investigational Site Moscow 105 229 Russian Federation Details
GSK Investigational Site Moscow 121309 Russian Federation Details
GSK Investigational Site Nizhniy Novgorod 603081 Russian Federation Details
GSK Investigational Site Omsk 644013 Russian Federation Details
GSK Investigational Site Saint-Petersburg 197022 Russian Federation Details
GSK Investigational Site Saint-Petersburg 197758 Russian Federation Details
GSK Investigational Site A CoruNa 15006 Spain Details
GSK Investigational Site Barcelona 08025 Spain Details
GSK Investigational Site Barcelona 08035 Spain Details
GSK Investigational Site Barcelona 08036 Spain Details
GSK Investigational Site Cordoba 140044 Spain Details
GSK Investigational Site Gerona 17007 Spain Details
GSK Investigational Site Las Palmas De Gran Canar 35016 Spain Details
GSK Investigational Site Madrid 28009 Spain Details
GSK Investigational Site Madrid 28027 Spain Details
GSK Investigational Site Madrid 28041 Spain Details
GSK Investigational Site Madrid 28046 Spain Details
GSK Investigational Site Madrid 28050 Spain Details
GSK Investigational Site Madrid 28222 Spain Details
GSK Investigational Site Malaga 29010 Spain Details
GSK Investigational Site PamplonaNavarra 31008 Spain Details
GSK Investigational Site Santander 39008 Spain Details
GSK Investigational Site Zaragoza 50009 Spain Details
GSK Investigational Site Gavle SE-801 87 Sweden Details
GSK Investigational Site Stockholm SE-171 76 Sweden Details
GSK Investigational Site Uppsala SE-751 85 Sweden Details
GSK Investigational Site Lausanne 1011 Switzerland Details
GSK Investigational Site Ankara 06010 Turkey Details
GSK Investigational Site Ankara 06100 Turkey Details
GSK Investigational Site Ankara 06520 Turkey Details
GSK Investigational Site Edirne 22030 Turkey Details
GSK Investigational Site Istanbul 34662 Turkey Details
GSK Investigational Site Bournemouth BH7 7DW United Kingdom Details
GSK Investigational Site Dundee DD1 9SY United Kingdom Details
GSK Investigational Site Middlesex HA6 2RN United Kingdom Details
GSK Investigational Site Oxford OX3 7LJ United Kingdom Details
GSK Investigational Site Wrexham LL13 7TD United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field